Cited by 571Glioma Diagnosis and TreatmentCancer-related Molecular PathwaysChromatin Remodeling and Cancer

The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.

Frequent Co‐Alterations of TP53, p16/CDKN2A, p14 ARF , PTEN Tumor Suppressor Genes in Human Glioma Cell Lines.

Open access

Ishii, Nobuaki, Maier, Daniel, Merlo, Adrian, Tada, Mitsuhiro, Sawamura, Yutaka, Diserens, Annie‐Claire, Van Meir, Erwin G.·1999·Brain Pathology

DOI 10.1111/j.1750-3639.1999.tb00536.xPMC PMC8098486

Open this paper in CoChat — free account

Abstract

In this study we established the simultaneous status of TP53, p16, p14ARF and PTEN tumor suppressor genes in 34 randomly chosen human glioma cell lines. Nine cell lines (26.4%) harbored mutations or deletions in all four tumor suppressor genes and 22 cell lines (64%) had alterations in at least three. Mutations/deletions were found at the following frequencies: TP53 (76.5%), p14ARF (64.7%), p16 (64.7%), PTEN (73.5%). Thus, there was a high incidence of alterations in the cellular pathways involving the p53 transcription factor (94.1%), the retinoblastoma protein (64.7%) and the PTEN phosphatase (73.5%) and 91% of cell lines carried mutations in two or more pathways. This provides the first clear genetic evidence that these tumor suppressors participate in biological pathways which are functioning separately/independently in glioma cells. The status of the gene alterations did not correlate with tumorigenicity in immunocompromized mice or any clinical parameters. Although the mutation rate was higher in glioma cell lines than that reported for glioma tissues, the alterations were molecularly representative of those found in adult de novo glioblastoma. This study highlights the importance of developing therapeutic approaches applicable to tumors with a broad range of genetic alterations and also provides an invaluable panel of glioma cell lines to make this possible.

Integrity signals

Registry

Crossref · 10.1111/j.1750-3639.1999.tb00536.x

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,742
5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E. W., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,992
Self-citation
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521
Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
Kamb, A., Shattuck-Eidens, D. M., Eeles, R. A., Liu, Q., Gruis, N. A., Ding, W., Hussey, C. E., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0994-22 · Cited by 855
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
Myers, M. P., Stolarov, J. P., Eng, C., Li, J., Wang, S. I., Wigler, M. H., Parsons, R. E., & Tonks, N. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9052 · Cited by 775

Show all 48 references

Research works printed but not linked: 1

KleihuesP CaveneeWK(1997).Pathology and Genetics of Tumors of the Nervous System.International Agency for Research on Cancer: 1st edition Lyon.

Sorted by citations

Items 201–300 of 571

HDJ-2 as a Target for Radiosensitization of Glioblastoma Multiforme Cells by the Farnesyltransferase Inhibitor R115777 and the Role of the p53/p21 Pathway
Wang, C., Liao, Y., Mischel, P. S., Iwamoto, K. S., Cacalano, N. A., & McBride, W. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0185 · Cited by 60
Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas
Choi, S. H., Stuckey, D. W., Pignatta, S., Reinshagen, C., Khalsa, J. K., Roozendaal, N., Martínez‐Quintanilla, J., Tamura, K., Keleş, E., & Shah, K. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0077 · Cited by 59
Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?
He, Y., & Kaina, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071562 · Cited by 62
PTEN decreases in vivo vascularization of experimental gliomas in spite of proangiogenic stimuli.
Abé, T., Terada, K., Wakimoto, H., Inoüe, R., Tyminski, E., Bookstein, R., Basilion, J. P., & Chiocca, E. A. (2003) · PubMed · Cited by 59
DNA fingerprinting of glioma cell lines and considerations on similarity measurements
Bady, P., Diserens, A.-C., Castella, V., Kalt, S., Heinimann, K., Hamou, M.-F., Delorenzi, M., & Hegi, M. E. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos072 · Cited by 57
Self-citation
The effect of photoinitiators on intracellular AKT signaling pathway in tissue engineering application
Xu, L., Sheybani, N., Yeudall, W. A., & Yang, H. (2015) · Biomaterials Science · doi:10.1039/c4bm00245h · Cited by 60
Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivo
Karpel‐Massler, G., Ramani, D., Shu, C., Halatsch, M., Westhoff, M., Bruce, J. N., Canoll, P., & Siegelin, M. D. (2016) · Oncotarget · doi:10.18632/oncotarget.9257 · Cited by 59
Dual Growth Arrest Pathways in Astrocytes and Astrocytic Tumors in Response to Raf-1 Activation
Fanton, C. P., McMahon, M., & Pieper, R. O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011514200 · Cited by 58
Regulation of glioblastoma cell invasion by PKCι and RhoB
Baldwin, R. M., Parolin, D. A. E., & Lorimer, I. A. J. (2008) · Oncogene · doi:10.1038/sj.onc.1211027 · Cited by 57
High‐molecular‐weight tropomyosins localize to the contractile rings of dividing CNS cells but are absent from malignant pediatric and adult CNS tumors
Hughes, J. A. I., Cooke‐Yarborough, C., Chadwick, N. C., Schevzov, G., Arbuckle, S. M., Gunning, P. W., & Weinberger, R. P. (2003) · Glia · doi:10.1002/glia.10174 · Cited by 57
Synthetic Cannabinoids Induce Autophagy and Mitochondrial Apoptotic Pathways in Human Glioblastoma Cells Independently of Deficiency in TP53 or PTEN Tumor Suppressors
Ellert‐Miklaszewska, A., Ciechomska, I. A., & Kaminska, B. (2021) · Cancers · doi:10.3390/cancers13030419 · Cited by 56
Structural mutation analysis of PTEN and its genotype‐phenotype correlations in endometriosis and cancer
Smith, I. N., & Briggs, J. M. (2016) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25105 · Cited by 55
The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma
Li, Z., Mbah, N. E., Overmeyer, J. H., Sarver, J. G., George, S., Trabbic, C. J., Erhardt, P., & Maltese, W. A. (2019) · BMC Cancer · doi:10.1186/s12885-019-5288-y · Cited by 56
The chemokine GRO-α (CXCL1) confers increased tumorigenicity to glioma cells
Zhou, Y., Zhang, J., Liu, Q., Bell, R. B., Muruve, D. A., Forsyth, P. A., Arcellana‐Panlilio, M. Y., Robbins, S. M., & Yong, V. W. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi182 · Cited by 55
Autophagic cell death induced by TrkA receptor activation in human glioblastoma cells
Hansen, K., Wagner, B., Hamel, W., Schweizer, M., Haag, F., Westphal, M., & Lamszus, K. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04753.x · Cited by 54
Evodiamine inhibits the proliferation of human osteosarcoma cells by blocking PI3K/Akt signaling
Meng, Z., WU, N., Liu, Y., Shu, K.-J., ZOU, X., Zhang, R., Pi, C.-J., He, B., Ke, Z., Chen, L., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4084 · Cited by 53
Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness
Moniz, S., Martinho, O., Pinto, F., Sousa, B., Loureiro, C. A., Oliveira, M. J., Moita, L. F., Honavar, M., Pinheiro, C., Pires, M. M., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds405 · Cited by 52
Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma
Davare, M. A., Henderson, J. J., Agarwal, A., Wagner, J. P., Iyer, S. R., Shah, N., Woltjer, R. L., Somwar, R., Gilheeney, S. W., DeCarvalo, A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1052 · Cited by 54
MiR‐16‐5p is frequently down‐regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy
Krell, A., Wolter, M., Stojcheva, N., Hertler, C., Liesenberg, F., Zapatka, M., Weller, M., Malzkorn, B., & Reifenberger, G. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12532 · Cited by 53
Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death
Ronellenfitsch, M. W., Brucker, D. P., Burger, M. C., Wolking, S., Tritschler, F., Rieger, J., Wick, W., Weller, M., & Steinbach, J. P. (2009) · Brain · doi:10.1093/brain/awp093 · Cited by 53
p53 isoform profiling in glioblastoma and injured brain
Takahashi, R., Giannini, C., Sarkaria, J. N., Schroeder, M., Rogers, J., Mastroeni, D., & Scrable, H. J. (2012) · Oncogene · doi:10.1038/onc.2012.322 · Cited by 52
Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival
Herzog, S., Fink, M. A., Weitmann, K., Friedel, C., Hadlich, S., Langner, S., Kindermann, K., Holm, T., Böhm, A., Eskilsson, E., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou216 · Cited by 52
Droplet digital PCR-based analyses for robust, rapid, and sensitive molecular diagnostics of gliomas
Wolter, M., Felsberg, J., Malzkorn, B., Kaulich, K., & Reifenberger, G. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01335-6 · Cited by 50
Antiproliferative effects of Tubi-bee propolis in glioblastoma cell lines
Borges, K. S., Brassesco, M. S., Scrideli, C. A., Soares, A. E. E., & Tone, L. G. (2011) · Genetics and Molecular Biology · doi:10.1590/s1415-47572011000200024 · Cited by 50
Preclinical Models and Technologies in Glioblastoma Research: Evolution, Current State, and Future Avenues
Slika, H., Karimov, Z., Alimonti, P., Abou‐Mrad, T., Fazio, E. D., Alomari, S., & Tyler, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216316 · Cited by 52
Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide
Montaldi, A. P., & Sakamoto-Hojo, E. (2013) · Clinical and Experimental Medicine (Testo stampato) · doi:10.1007/s10238-012-0201-x · Cited by 42
Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas
Birlik, B., Canda, Ş., & Özer, E. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00763.x · Cited by 50
Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics
St‐Cœur, P., Poitras, J., Čuperlović‐Culf, M., Touaibia, M., & Morin, P. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1899-6 · Cited by 48
Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy
Shchors, K., Persson, A. I., Rostker, F., Tihan, T., Lyubynska, N., Li, N., Swigart, L. B., Berger, M. S., Hanahan, D., Weiss, W. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219142110 · Cited by 49
ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells
Cristofanon, S., & Fulda, S. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.163 · Cited by 48
Interferon-β Induces Loss of Spherogenicity and Overcomes Therapy Resistance of Glioblastoma Stem Cells
Hertler, C., Roth, P., Silginer, M., Florea, A., Lamszus, K., Frei, K., Deenen, R., Reifenberger, G., & Weller, M. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0772 · Cited by 49
The Effects of Histone Deacetylase Inhibitors on Glioblastoma-Derived Stem Cells
Alvarez, A. A., Field, M., Bushnev, S., Longo, M. S., & Sugaya, K. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0329-0 · Cited by 47
Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells
de la Peña, L., Burgan, W. E., Carter, D. J., Hollingshead, M. G., Satyamitra, M. M., Camphausen, K. A., & Tofilon, P. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0091 · Cited by 47
Constitutive Notch2 signaling in neural stem cells promotes tumorigenic features and astroglial lineage entry
Tchorz, J. S., Tomé, M., Cloëtta, D., Sivasankaran, B., Grzmil, M., Huber, R. M., Rutz-Schatzmann, F., Kirchhoff, F., Schaeren‐Wiemers, N., Gassmann, M., et al. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.65 · Cited by 47
Self-citation
Considering the Experimental Use of Temozolomide in Glioblastoma Research
Herbener, V. J., Burster, T., Goreth, A., Pruss, M., von Bandemer, H., Baisch, T., Fitzel, R., Siegelin, M. D., Karpel‐Massler, G., Debatin, K., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8060151 · Cited by 50
Preclinical models of glioblastoma: limitations of current models and the promise of new developments
Liu, P., Griffiths, S., Veljanoski, D., Vaughn-Beaucaire, P. C., Speirs, V., & Brüning‐Richardson, A. (2021) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2021.20 · Cited by 47
Central nervous system
Adamson, D. C., Rasheed, B. A., McLendon, R. E., & Bigner, D. D. (2011) · Cancer Biomarkers · doi:10.3233/cbm-2011-0177 · Cited by 45
Deltex-1 Activates Mitotic Signaling and Proliferation and Increases the Clonogenic and Invasive Potential of U373 and LN18 Glioblastoma Cells and Correlates with Patient Survival
Huber, R. M., Rajski, M., Sivasankaran, B., Moncayo, G. E., Hemmings, B. A., & Merlo, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057793 · Cited by 44
Self-citation
A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy
Ströbele, S., Schneider, M. B., Schneele, L., Siegelin, M. D., Nonnenmacher, L., Zhou, S., Karpel‐Massler, G., Westhoff, M., Halatsch, M., & Debatin, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131670 · Cited by 45
Co-delivery of GOLPH3 siRNA and gefitinib by cationic lipid-PLGA nanoparticles improves EGFR-targeted therapy for glioma
Ye, C., Pan, B., Xu, H., Zhao, Z., Shen, J., Lu, J. L., Yu, R., & Liu, H. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01843-4 · Cited by 44
O6-methylguanine-DNA methyltransferase is downregulated in transformed astrocyte cells: implications for anti-glioma therapies
Sasai, K., Akagi, T., Aoyanagi, E., Tabu, K., Kaneko, S., & Tanaka, S. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-36 · Cited by 44
MicroRNAs Regulate Cell Cycle and Cell Death Pathways in Glioblastoma
Sati, I. S. E. E., & Parhar, I. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413550 · Cited by 45
Attractin Is Elevated in the Cerebrospinal Fluid of Patients with Malignant Astrocytoma and Mediates Glioma Cell Migration
Khwaja, F. W., Duke‐Cohan, J. S., Brat, D. J., & Meir, E. G. V. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1296 · Cited by 42
Apoptosis in gliomas and its role in their current and future treatment
Bögler, O. (2002) · Frontiers in bioscience · doi:10.2741/a928 · Cited by 41
Molecular regulation of angiogenesis and tumorigenesis by signal transduction pathways: evidence of predictable and reproducible patterns of synergy in diverse neoplasms
Arbiser, J. L. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.09.013 · Cited by 43
TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy
Noor, H., Briggs, N., McDonald, K. L., Holst, J., & Vittorio, O. (2021) · Cancers · doi:10.3390/cancers13215362 · Cited by 42
Expression signatures of DNA repair genes correlate with survival prognosis of astrocytoma patients
de Sousa, J. F., Torrieri, R., Serafim, R. B., Cristofaro, L. F. M. D., Escanfella, F. D., Ribeiro, R. M. P., Zanette, D. L., Paçó‐Larson, M. L., Silva, W. A., Tirapelli, D. P. D. C., et al. (2017) · Tumor Biology · doi:10.1177/1010428317694552 · Cited by 41
Temozolomide induces autophagy in primary and established glioblastoma cells in an EGFR independent manner
Würstle, S. M., Schneider, F., Ringel, F. A., Gempt, J., Lämmer, F., Delbridge, C., Wu, W. E., & Schlegel, J. (2017) · Oncology Letters · doi:10.3892/ol.2017.6107 · Cited by 41
Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs
Haas, B., Klinger, V., Keksel, C., Bonigut, V., Kiefer, D., Caspers, J., Walther, J., Wos-Maganga, M., Weickhardt, S., Röhn, G., et al. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0565-4 · Cited by 41
Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma
Ito, H., Watari, K., Shibata, T., Miyamoto, T., Murakami, Y., Nakahara, Y., Izumi, H., Wakimoto, H., Kuwano, M., Abé, T., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0438 · Cited by 41
TRPM7 Induces Mechanistic Target of Rap1b Through the Downregulation of miR-28-5p in Glioma Proliferation and Invasion
Wan, J., Guo, A. A., Chowdhury, I., Guo, S., Hibbert, J. M., Wang, G., & Liu, M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01413 · Cited by 41
Noscapine induces apoptosis in human glioma cells by an apoptosis-inducing factor-dependent pathway
Newcomb, E. W., Lukyanov, Y., Smirnova, I., Schnee, T., & Zagzag, D. (2008) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3282ffd68d · Cited by 42
Mammalian target of rapamycin complex 1 activation sensitizes human glioma cells to hypoxia-induced cell death
Thiepold, A., Lorenz, N. I., Foltyn‐Dumitru, M., Engel, A. L., Divé, I., Urban, H., Heller, S., Bruns, I., Hofmann, U., Dröse, S., et al. (2017) · Brain · doi:10.1093/brain/awx196 · Cited by 42
Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
Naumann, U., Kügler, S., Wolburg, H., Wick, W., Rascher, G., Schulz, J. B., Conseiller, E., Bähr, M., & Weller, M. (2001) · PubMed · Cited by 41
Activation of extracellular-regulated kinases by normal and mutant EGF receptors
Lorimer, I. A. J., & Lavictoire, S. J. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00129-4 · Cited by 41
Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivo
Karpel‐Massler, G., Banu, M. A., Shu, C., Halatsch, M., Westhoff, M., Bruce, J. N., Canoll, P., & Siegelin, M. D. (2016) · Oncotarget · doi:10.18632/oncotarget.7302 · Cited by 40
Absence of GAPDH regulation in tumor-cells of different origin under hypoxic conditions in – vitro
Said, H. M., Polat, B., Hagemann, C., Anacker, J., Flentje, M. P., & Vordermark, D. (2009) · BMC Research Notes · doi:10.1186/1756-0500-2-8 · Cited by 40
PAX6 suppression of glioma angiogenesis and the expression of vascular endothelial growth factor A
Zhou, Y., Hu, Y., Mayes, D. A., Siegel, E. R., Kim, J. G., Mathews, M. S., Hsu, N., Eskander, D., Yu, O., Tromberg, B. J., et al. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9963-8 · Cited by 40
A mosaic mouse model of astrocytoma identifies αvβ8 integrin as a negative regulator of tumor angiogenesis
Tchaicha, J. H., Mobley, A. K., Hossain, M. G., Aldape, K., & McCarty, J. H. (2010) · Oncogene · doi:10.1038/onc.2010.199 · Cited by 40
Betulinic Acid Derivatives NVX-207 and B10 for Treatment of Glioblastoma—An in Vitro Study of Cytotoxicity and Radiosensitization
Bache, M., Bernhardt, S., Passin, S., Wichmann, H., Hein, A., Zschornak, M. P., Kappler, M., Taubert, H. W., Paschke, R., & Vordermark, D. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151119777 · Cited by 39
The effect of miR‐579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines
Kalhori, M. R., Irani, S., Soleimani, M., Arefian, E., & Kouhkan, F. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28935 · Cited by 38
Selective cell death of oncogenic Akt-transduced brain cancer cells by etoposide through reactive oxygen species–mediated damage
Oh, S.-Y., Sohn, Y.-W., Park, J., Park, H., Jeon, H.-M., Kim, T.-K., Lee, J.-S., Jung, J., Jin, X., Chung, Y. G., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0111 · Cited by 39
Growth inhibition of human malignant glioma cells induced by the PI3-K—specific inhibitor
Shingu, T., Yamada, K., Hara, N., Moritake, K., Osago, H., Terashima, M., Uemura, T., Yamasaki, T., & Tsuchiya, M. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.98.1.0154 · Cited by 39
Pre-treatment or Post-treatment of Human Glioma Cells With BIX01294, the Inhibitor of Histone Methyltransferase G9a, Sensitizes Cells to Temozolomide
Ciechomska, I. A., Marciniak, M. P., Jackl, J., & Kaminska, B. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01271 · Cited by 41
Genetic and signaling pathway alterations in glioblastoma relevance to novel targeted therapies
James, C. D. (2003) · Frontiers in bioscience · doi:10.2741/897 · Cited by 38
Cyclosporine a induces growth arrest or programmed cell death of human glioma cells
Żupańska, A. K., Dziembowska, M., Ellert‐Miklaszewska, A., Gawęda-Walerych, K., & Kaminska, B. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.05.010 · Cited by 38
Meningeal Melanocytoma Associated with Ipsilateral Nevus of Ota Presenting as Intracerebral Hemorrhage: Case Report
Hino, K., Nagane, M., Fujioka, Y., & Shiokawa, Y. (2005) · Neurosurgery · doi:10.1227/01.neu.0000159716.45457.bc · Cited by 38
AdΔ24 and the p53‐expressing variant AdΔ24‐p53 achieve potent anti‐tumor activity in glioma when combined with radiotherapy
Idema, S., Lamfers, M. L. M., van Beusechem, V. W., Noske, D. P., Heukelom, S., Moeniralm, S., Gerritsen, W. R., Vandertop, W. P., & Dirven, C. M. F. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1113 · Cited by 38
Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines
Said, H. M., Staab, A., Hagemann, C., Vince, G. H., Katzer, A., Flentje, M. P., & Vordermark, D. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9205-2 · Cited by 38
Inhibition of HDAC increases the senescence induced by natural polyphenols in glioma cells
Vargas, J. E., Filippi‐Chiela, E. C., Suhre, T., Kipper, F. C., Bonatto, D., & Lenz, G. (2014) · Biochemistry and Cell Biology · doi:10.1139/bcb-2014-0022 · Cited by 37
Activated Ras induces cytoplasmic vacuolation and non-apoptotic death in glioblastoma cells via novel effector pathways
Kaul, A., Overmeyer, J. H., & Maltese, W. A. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.11.010 · Cited by 37
Suppression of G-protein–Coupled Receptor Kinase 3 Expression Is a Feature of Classical GBM That Is Required for Maximal Growth
Woerner, B. M., Luo, J. R., Brown, K. R., Jackson, E., Dahiya, S. M., Mischel, P. S., Benovic, J., Piwnica-Worms, D. R., & Rubin, J. B. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0411 · Cited by 37
Scatter Factor/Hepatocyte Growth Factor Stimulation of Glioblastoma Cell Cycle Progression through G1 Is c-Myc Dependent and Independent of p27 Suppression, Cdk2 Activation, or E2F1-Dependent Transcription
Walter, K. A., Hossain, M. A., Luddy, C., Goel, N., Reznik, T. E., & Laterra, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2703-2715.2002 · Cited by 37
Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide
Lorenz, N. I., Sittig, A. C. M., Urban, H., Luger, A., Engel, A. L., Münch, C., Steinbach, J. P., & Ronellenfitsch, M. W. (2021) · Scientific Reports · doi:10.1038/s41598-021-93663-1 · Cited by 35
Glioblastoma cell secretome: Analysis of three glioblastoma cell lines reveal 148 non-redundant proteins
Polisetty, R. V., Gupta, M. K., Nair, S. C., Ramamoorthy, K., Tiwary, S., Shiras, A., Chandak, G. R., & Sirdeshmukh, R. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.05.002 · Cited by 36
Microtubule actin cross-linking factor 1, a novel target in glioblastoma
Afghani, N., Mehta, T. R., Wang, J., Tang, N., Skalli, O., & Quick, Q. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3798 · Cited by 36
Heme Oxygenase-1 in Central Nervous System Malignancies
Sferrazzo, G., Rosa, M. D., Barone, E., Volti, G. L., Musso, N., Tibullo, D., & Barbagallo, I. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051562 · Cited by 36
Promoter and enhancer RNAs regulate chromatin reorganization and activation of miR-10b/HOXD locus, and neoplastic transformation in glioma
Deforzh, E., Uhlmann, E. J., Das, E., Galitsyna, A. A., Arora, R., Saravanan, H., Rabinovsky, R., Wirawan, A., Teplyuk, N. M., Fatimy, R. E., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.03.018 · Cited by 37
Dual Effect of Serum Amyloid A on the Invasiveness of Glioma Cells
Knebel, F. H., Albuquerque, R. C., Massaro, R. R., Maria–Engler, S. S., & Čampa, A. (2013) · Mediators of Inflammation · doi:10.1155/2013/509089 · Cited by 37
Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells
Barrett, J. W., Alston, L. R., Wang, F., Stanford, M. M., Gilbert, P. A., Gao, X., Jimenez, J., Villeneuve, D., Forsyth, P. A., & McFadden, G. (2007) · Journal of NeuroVirology · doi:10.1080/13550280701591526 · Cited by 35
The Akt/protein kinase B-dependent anti-apoptotic pathway and the mitogen-activated protein kinase cascade are alternatively activated in human glioblastoma multiforme
Schlegel, J., Piontek, G., Budde, B., Neff, F., & Kraus, A. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00515-2 · Cited by 36
Multiple lesions in receptor tyrosine kinase pathway determine glioblastoma response to pan-ERBB inhibitor PF-00299804 and PI3K/mTOR dual inhibitor PF-05212384
Zhu, Y., & Shah, K. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28585 · Cited by 36
ZFX regulates glioma cell proliferation and survival in vitro and in vivo
Zhu, Z., Li, K., Xu, D., Liu, Y., Tang, H., Xie, Q. M., Xie, L., Liu, J., Wang, H., Gong, Y., et al. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-1032-z · Cited by 35
Genetic mapping of the sex-linked barring gene in the chicken
Dorshorst, B., & Ashwell, C. M. (2009) · Poultry Science · doi:10.3382/ps.2009-00134 · Cited by 35
EGFR-dependent migration of glial cells is mediated by reorganisation of N-cadherin
Rappl, A., Piontek, G., & Schlegel, J. (2008) · Journal of Cell Science · doi:10.1242/jcs.027995 · Cited by 35
Structure–activity relationship of 2,2-dimethyl-2H-chromene based arylsulfonamide analogs of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, a novel small molecule hypoxia inducible factor-1 (HIF-1) pathway inhibitor and anti-cancer agent
Mun, J.-Y., Jabbar, A. A., Devi, N. S., Liu, Y., Meir, E. G. V., & Goodman, M. M. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.04.064 · Cited by 35
Adenoviral Natural Born Killer Gene Therapy for Malignant Glioma
Naumann, U., Schmidt, F., Wick, W., Frank, B., Weit, S., Gillissen, B. F., Daniel, P. T., & Weller, M. (2003) · Human Gene Therapy · doi:10.1089/104303403767740777 · Cited by 35
p53 Mutant Human Glioma Cells Are Sensitive to UV-C-Induced Apoptosis Due to Impaired Cyclobutane Pyrimidine Dimer Removal
Batista, L. F. Z., Roos, W. P., Kaina, B., & Menck, C. F. M. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0428 · Cited by 37
New insights into the anticancer activity of carnosol: p53 reactivation in the U87MG human glioblastoma cell line
Giacomelli, C., Natali, L., Trincavelli, M. L., Daniele, S., Bertoli, A., Flamini, G., Braca, A., & Martini, C. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.02.019 · Cited by 33
Caveolin‐1 expression is maintained in rat and human astroglioma cell lines
Cameron, P. L., Liu, C., Smart, D. D., Hantus, S. T., Fick, J. R., & Cameron, R. S. (2002) · Glia · doi:10.1002/glia.10036 · Cited by 35
PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1
Gont, A., Hanson, J. E. L., Lavictoire, S. J., Parolin, D. A. E., Daneshmand, M., Restall, I. J., Soucie, M., Nicholas, G. A., Woulfe, J., Kassam, A. B., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1164 · Cited by 33
Death receptor-mediated apoptosis in human malignant glioma cells: Modulation by the CD40/CD40L system
Wischhusen, J., Schneider, D., Mittelbronn, M. G. A., Meyermann, R., Engelmann, H., Jung, G., Wiendl, H., & Weller, M. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.01.005 · Cited by 35
Sulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors
Tan, C., de Noronha, R. G., Devi, N. S., Jabbar, A. A., Kaluz, Š., Liu, Y., Mooring, S. R., Nicolaou, K. C., Wang, B., & Meir, E. G. V. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.06.099 · Cited by 34
Polyploid/Multinucleated Giant and Slow-Cycling Cancer Cell Enrichment in Response to X-ray Irradiation of Human Glioblastoma Multiforme Cells Differing in Radioresistance and TP53/PTEN Status
Alhaddad, L., Chuprov‐Netochin, R. N., Pustovalova, M. V., Osipov, A. N., & Leonov, S. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021228 · Cited by 34
Exonization of Alu-generated Splice Variants in the Survivin Gene of Human and Non-human Primates
Mola, G., Vela, E., Fernández‐Figueras, M. T., Isamat, M., & Muñoz-Mármol, A. M. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.11.089 · Cited by 36
Clinically relevant doses of chemotherapy agents reversibly block formation of glioblastoma neurospheres
Mihaliak, A. M., Gilbert, C. A., Li, L., Daou, M., Moser, R. P., Reeves, A., Cochran, B., & Ross, A. H. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.04.005 · Cited by 34
Cisplatin associated with LY294002 increases cytotoxicity and induces changes in transcript profiles of glioblastoma cells
Carminati, P. O., Donaires, F. S., Marques, M. M. C., Donadi, E. A., Passos, G. A. S., & Sakamoto‐Hojo, E. T. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2849-z · Cited by 34
The CDKN2A G500 Allele Is More Frequent in GBM Patients with No Defined Telomere Maintenance Mechanism Tumors and Is Associated with Poorer Survival
Royds, J. A., Nadaf, S. A., Wiles, A. K., Chen, Y.-J., Ahn, A., Shaw, A., Bowie, S., Lam, F., Baguley, B. C., Braithwaite, A. W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026737 · Cited by 34
Tocotrienol-Rich Fraction, [6]-Gingerol and Epigallocatechin Gallate Inhibit Proliferation and Induce Apoptosis of Glioma Cancer Cells
Rahman, A. A., Makpol, S., Jamal, R. A., Harun, R., Mokhtar, N. M., & Ngah, W. Z. W. (2014) · Molecules · doi:10.3390/molecules190914528 · Cited by 33
Caffeine Confers Radiosensitization of PTEN-Deficient Malignant Glioma Cells by Enhancing Ionizing Radiation–Induced G1 Arrest and Negatively Regulating Akt Phosphorylation
Sinn, B., Tallen, G. R. N., Schroeder, G., Grassl, B., Schulze, J., Budach, V., & Tinhofer, I. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0498 · Cited by 33

Authors: Ishii, N., Maier, D., Merlo, A., Tada, M., Sawamura, Y., Diserens, A., & Van Meir, E. G.
Affiliations: Centre Hospitalier Universitaire Vaudois (CH)
University Hospital of Basel (CH)
Hokkaido University (JP)
ORCID: Ishii, Nobuaki
Tada, Mitsuhiro
Venue: Brain Pathology
Publisher: Wiley
Published: 1999-07
Volume: 9
Issue: 3
Pages: 469-479
ISSN: 1015-6305 (ISSN-L)
1750-3639
DOI: 10.1111/j.1750-3639.1999.tb00536.x
PMC: PMC8098486
OpenAlex: W2155140015
Cited by: 569
References: 48
Citations by year: 2026: 9 · 2025: 10 · 2024: 24 · 2023: 20 · 2022: 21 · 2021: 23 · 2020: 13 · 2019: 25 · 2018: 14 · 2017: 16 · 2016: 14 · 2015: 27 · 2014: 33 · 2013: 25 · 2012: 34
FWCI: 11.06
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 2470 d)
Locations: Brain Pathology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
IRIS (submittedVersion)
SERVAL (Université de Lausanne) (submittedVersion)
Topics: Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: glioma cell lines, TP53 mutation, CDKN2A/p16, p14ARF, PTEN, p53 pathway, glioblastoma, tumorigenicity, genetic alterations
MeSH terms: Adult, Aged, Animals, Brain Neoplasms, Child, DNA Mutational Analysis, Female, Glioma, Humans, Male, Mice, Nude, Middle Aged, Neoplasm Transplantation, Neoplastic Processes, Phosphoric Monoester Hydrolases, Proteins, Sex Factors, Tumor Cells, Cultured, Genes, Tumor Suppressor, Tumor Suppressor Protein p53, Point Mutation, Sequence Deletion, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Proteins, Tumor Suppressor Protein p14ARF, PTEN Phosphohydrolase, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Frequent Co‐Alterations of TP53, p16/CDKN2A, p14 ARF , PTEN Tumor Suppressor Genes in Human Glioma Cell Lines.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks